ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.

Paul L. Nguyen, Ayal Aizer, Dean G. Assimos, Anthony V. D'Amico, Steven J. Frank, Alexander R. Gottschalk, Gary S. Gustafson, I. Chow Joe Hsu, Patrick W. McLaughlin, Gregory Merrick, Seth A. Rosenthal, Timothy N. Showalter, A. V. Taira, Neha Vapiwala, Yoshiya Yamada, Brian J. Davis, College of Radiology, Expert Panel on Radiation OncologyProstate American College of Radiology, Expert Panel on Radiation OncologyProstate

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

To present the most updated American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of external-beam radiation to manage stage T1 and T2 prostate cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel summarized the most recent and relevant literature on the topic and voted on 3 clinical variants illustrating the appropriate dose, techniques, and use of adjuvant hormone therapy with external-beam radiation for low-risk, intermediate-risk, and high-risk prostate cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. External-beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate use of external-beam radiation for prostate cancer.

Original languageEnglish (US)
Pages (from-to)278-288
Number of pages11
JournalAmerican Journal of Clinical Oncology
Volume37
Issue number3
StatePublished - 2014

Fingerprint

Prostatic Neoplasms
Guidelines
Radiation
Expert Testimony
Radiology
Hormones
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nguyen, P. L., Aizer, A., Assimos, D. G., D'Amico, A. V., Frank, S. J., Gottschalk, A. R., ... American College of Radiology, Expert Panel on Radiation OncologyProstate, C. O. R. E. P. O. R. O. (2014). ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. American Journal of Clinical Oncology, 37(3), 278-288.

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. / Nguyen, Paul L.; Aizer, Ayal; Assimos, Dean G.; D'Amico, Anthony V.; Frank, Steven J.; Gottschalk, Alexander R.; Gustafson, Gary S.; Hsu, I. Chow Joe; McLaughlin, Patrick W.; Merrick, Gregory; Rosenthal, Seth A.; Showalter, Timothy N.; Taira, A. V.; Vapiwala, Neha; Yamada, Yoshiya; Davis, Brian J.; American College of Radiology, Expert Panel on Radiation OncologyProstate, College of Radiology, Expert Panel on Radiation OncologyProstate.

In: American Journal of Clinical Oncology, Vol. 37, No. 3, 2014, p. 278-288.

Research output: Contribution to journalArticle

Nguyen, PL, Aizer, A, Assimos, DG, D'Amico, AV, Frank, SJ, Gottschalk, AR, Gustafson, GS, Hsu, ICJ, McLaughlin, PW, Merrick, G, Rosenthal, SA, Showalter, TN, Taira, AV, Vapiwala, N, Yamada, Y, Davis, BJ & American College of Radiology, Expert Panel on Radiation OncologyProstate, COREPORO 2014, 'ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.', American Journal of Clinical Oncology, vol. 37, no. 3, pp. 278-288.
Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR et al. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. American Journal of Clinical Oncology. 2014;37(3):278-288.
Nguyen, Paul L. ; Aizer, Ayal ; Assimos, Dean G. ; D'Amico, Anthony V. ; Frank, Steven J. ; Gottschalk, Alexander R. ; Gustafson, Gary S. ; Hsu, I. Chow Joe ; McLaughlin, Patrick W. ; Merrick, Gregory ; Rosenthal, Seth A. ; Showalter, Timothy N. ; Taira, A. V. ; Vapiwala, Neha ; Yamada, Yoshiya ; Davis, Brian J. ; American College of Radiology, Expert Panel on Radiation OncologyProstate, College of Radiology, Expert Panel on Radiation OncologyProstate. / ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. In: American Journal of Clinical Oncology. 2014 ; Vol. 37, No. 3. pp. 278-288.
@article{7e6bdc181feb4d8ca7b93499c99b6de8,
title = "ACR Appropriateness Criteria{\circledR} Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.",
abstract = "To present the most updated American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of external-beam radiation to manage stage T1 and T2 prostate cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel summarized the most recent and relevant literature on the topic and voted on 3 clinical variants illustrating the appropriate dose, techniques, and use of adjuvant hormone therapy with external-beam radiation for low-risk, intermediate-risk, and high-risk prostate cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. External-beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate use of external-beam radiation for prostate cancer.",
author = "Nguyen, {Paul L.} and Ayal Aizer and Assimos, {Dean G.} and D'Amico, {Anthony V.} and Frank, {Steven J.} and Gottschalk, {Alexander R.} and Gustafson, {Gary S.} and Hsu, {I. Chow Joe} and McLaughlin, {Patrick W.} and Gregory Merrick and Rosenthal, {Seth A.} and Showalter, {Timothy N.} and Taira, {A. V.} and Neha Vapiwala and Yoshiya Yamada and Davis, {Brian J.} and {American College of Radiology, Expert Panel on Radiation OncologyProstate}, {College of Radiology, Expert Panel on Radiation OncologyProstate}",
year = "2014",
language = "English (US)",
volume = "37",
pages = "278--288",
journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.

AU - Nguyen, Paul L.

AU - Aizer, Ayal

AU - Assimos, Dean G.

AU - D'Amico, Anthony V.

AU - Frank, Steven J.

AU - Gottschalk, Alexander R.

AU - Gustafson, Gary S.

AU - Hsu, I. Chow Joe

AU - McLaughlin, Patrick W.

AU - Merrick, Gregory

AU - Rosenthal, Seth A.

AU - Showalter, Timothy N.

AU - Taira, A. V.

AU - Vapiwala, Neha

AU - Yamada, Yoshiya

AU - Davis, Brian J.

AU - American College of Radiology, Expert Panel on Radiation OncologyProstate, College of Radiology, Expert Panel on Radiation OncologyProstate

PY - 2014

Y1 - 2014

N2 - To present the most updated American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of external-beam radiation to manage stage T1 and T2 prostate cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel summarized the most recent and relevant literature on the topic and voted on 3 clinical variants illustrating the appropriate dose, techniques, and use of adjuvant hormone therapy with external-beam radiation for low-risk, intermediate-risk, and high-risk prostate cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. External-beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate use of external-beam radiation for prostate cancer.

AB - To present the most updated American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of external-beam radiation to manage stage T1 and T2 prostate cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel summarized the most recent and relevant literature on the topic and voted on 3 clinical variants illustrating the appropriate dose, techniques, and use of adjuvant hormone therapy with external-beam radiation for low-risk, intermediate-risk, and high-risk prostate cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. External-beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate use of external-beam radiation for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=84908075497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908075497&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 278

EP - 288

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

SN - 0277-3732

IS - 3

ER -